Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

melasma/хемотерапија

Веза се чува у привремену меморију
ЧланциКлиничка испитивањаПатенти
Страна 1 од 23 резултати

Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE To report 12-year follow-up experience with topical mitomycin chemotherapy for diffuse and multifocal primary acquired melanosis (PAM) with atypia and conjunctival melanoma. METHODS Interventional case series of 16 patients. Mitomycin was a primary treatment for residual epithelial disease

Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE To clinically evaluate topical mitomycin chemotherapy in patients with diffuse, multifocal, or recurrent primary acquired melanosis with atypia and/or conjunctival malignant melanoma and to histopathologically study ocular tissue samples obtained before and after

Splenic melanosis during normal murine C57BL/6 hair cycle and after chemotherapy.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Cancer chemotherapy is associated with serious side effects, including temporary hair loss and impairment of pigmentation. We suspect that ectopic melanin deposition occurring due to chemotherapy may add to these effects worsening the already unpleasant symptoms. We associated the ectopic occurrence

Diffuse melanosis after chemotherapy-induced tumor lysis syndrome in a patient with metastatic melanoma.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Diffuse melanosis is a rare event associated with advanced metastatic malignant melanoma. A 35-year-old woman with stage IV melanoma is presented, who developed slate bluish-gray to brown discoloration of her skin after chemotherapy-induced tumor lysis syndrome. A number of studies were performed to

Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Surgical excision with cryotherapy is a well-established treatment option for malignant melanoma or primary acquired melanosis (PAM) with atypia of the conjunctiva and cornea. Topical chemotherapeutic agents such as mitomycin C (MMC) however, are increasingly finding use in clinical practice. A

The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE To report our results of 12 consecutive patients with conjunctival primary acquired melanosis (PAM) with atypia who were treated by topical Mitomycin C (MMC). METHODS Retrospective interventional consecutive case series. METHODS Twelve patients with PAM with atypia in one of their eyes who

Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
OBJECTIVE To evaluate the clinical features and risks for transformation of conjunctival primary acquired melanosis (PAM) into melanoma. METHODS Noncomparative case series. METHODS Three hundred eleven eyes with conjunctival PAM without melanoma at initial examination from a single-center tertiary

Primary malignant melanoma of uterine cervix with probable origin from benign cervical melanosis.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
We report a case of primary malignant melanoma of cervix which is a rare malignancy with only around 60 cases being reported. This patient presented with bleeding per vaginum. A large exophytic growth from cervix with black discolouration was seen. International Federation of Gynaecology and

Topical mitomycin treatment for primary acquired melanosis of the conjunctiva.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
A case of primary acquired melanosis of the conjunctiva primarily treated with topical mitomycin chemotherapy is presented. The patient underwent treatment with one 2-week course of topical mitomycin 0.02% four times daily, followed 4 weeks later by a 2-week course of topical mitomycin 0.04% four

[An autopsy case of neurocutaneous melanosis associated with intracerebral malignant melanoma].

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The authors reported the clinical course and the postmortem examination of a unique case of neurocutaneous melanosis with numerous anomalies and complications, which included congenital dislocation of lenses, hypogonadism, ectopia of prostatic duct, genuine phimose, retentio testis, psina bifida and

[Neurocutaneous melanosis--a case report].

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Neurocutaneous melanosis is a rare congenital phacomatosis characterized by the presence of large or multiple congenital melanocytic nevi and benign or malignant pigmented cell tumors of the leptomeninges. A 14-month-old boy was admitted with a recent history of vomiting and drowsiness. He was found

[Neurocutaneous melanosis and malignant melanoma].

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
A 36-year-old man presented with a giant congenital melanocytic nevus and multiple disseminated melanocytic nevi. After he had developed neurological symptoms (grand mal seizures), a cerebral metastasis of a malignant melanoma without a primary melanoma was found. The patient was diagnosed as having

[Neurocutaneous melanosis. Report of a case].

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The clinical, laboratorial and radiological features of a 3-month-old child with neurocutaneous melanosis are described. The patient was born with multiple disseminated benign cutaneous nevi, proven by skin-biopsy, and presented with drug-resistant seizures and psycho-motor retardation. Serial

Giant congenital melanocytic nevi and neurocutaneous melanosis.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Introduction. The major medical concern with giant congenital melanocytic nevi CMN is high risk of developing cutaneous melanoma, leptomeningeal melanoma, and neurocutaneous melanocytosis. Case Report. A 30-year-old woman with a giant congenital melanocytic nevus covering nearly the entire right

Neurocutaneous melanosis and the Dandy-Walker complex: an uncommon but not so insignificant association.

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND Neurocutaneous melanosis represents a rare congenital but nonheritable phakomatosis defined as the association of giant or multiple congenital nonmalignant melanocytic nevi with leptomeningeal melanosis or melanoma of the central nervous system. METHODS We describe the case of an
Придружите се нашој
facebook страници

Најкомплетнија база лековитог биља подржана науком

  • Ради на 55 језика
  • Биљни лекови потпомогнути науком
  • Препознавање биљака по слици
  • Интерактивна ГПС мапа - означите биље на локацији (ускоро)
  • Читајте научне публикације повезане са вашом претрагом
  • Претражите лековито биље по њиховим ефектима
  • Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима

Google Play badgeApp Store badge